فرز حسب
Keyphrases
Anti-HBs Antibody
20%
Clinical Trial Registry
20%
Geometric Mean Concentration
40%
HBs Antigen
20%
Healthy Adults
100%
Hepatitis B
20%
Hepatitis B Surface Antigen (HBsAg)
40%
Hepatitis B Vaccine
100%
High Responder
40%
Immunogenicity
20%
Phase IV Study
100%
Pre-large
20%
PreS2
20%
Rapid Onset
20%
Recombinant Hepatitis B Vaccine
20%
Safety Profile
20%
Sci-B-Vac
20%
Second Dose
20%
Seroprotection
100%
Vaccination
20%
Vaccine Dose
20%
Vaccine Licensure
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
50%
Hepatitis B
50%
Hepatitis B Antibody
100%
Hepatitis B Vaccine
100%
Hexachlorophene
50%
Immunogenicity
50%
Normal Human
50%
Phase IV
100%
Recombinant Hepatitis B Vaccine
50%
Immunology and Microbiology
Arm
50%
Hepatitis B
50%
Hepatitis B Surface Antibody
100%
Hepatitis B Vaccine
100%
Immunogenicity
50%
Normal Human
50%
Recombinant Hepatitis B Vaccine
50%
Titer
100%
Medicine and Dentistry
Arm
50%
Clinical Trial
50%
Hepatitis B
50%
Hepatitis B Antibody
100%
Hepatitis B Vaccine
100%
Hexachlorophene
50%
Immunogenicity
50%
Recombinant Hepatitis B Vaccine
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
50%
Immunogenicity
50%
Normal Human
50%
Recombinant
50%
Titer
100%